|
2024-08-14 |
2024-03-25 |
S
Sale
|
TZIANABOS ARTHUR
Non-Executive Director
|
265
-3.2%
24.20
USD 6,413
|
265
-3.2%
|
24.20
|
USD 6,413
|
|
|
2024-04-23 |
2024-03-25 |
PS
Planned sale
|
Michaud Charles Jr
See Remarks
Officer
|
75
-7.5%
24.20
USD 1,815
|
75
-7.5%
|
24.20
|
USD 1,815
|
|
|
2024-04-23 |
2024-03-25 |
PS
Planned sale
|
Alloway Paul
See Remarks
Officer
|
268
-9.4%
24.21
USD 6,488
|
268
-9.4%
|
24.21
|
USD 6,488
|
|
|
2024-02-15 |
2024-01-09 |
PS
Planned sale
|
TZIANABOS ARTHUR
Non-Executive Director
|
13,037
-9.2%
0.57
USD 7,445
|
13,037
-9.2%
|
0.57
|
USD 7,445
|
|
|
2024-01-05 |
2024-01-03 |
PS
Planned sale
|
Michaud Charles Jr
See Remarks
Officer
|
1,708
-12.8%
0.57
USD 975
|
1,708
-12.8%
|
0.57
|
USD 975
|
|
|
2024-01-05 |
2024-01-03 |
PS
Planned sale
|
Alloway Paul
See Remarks
Officer
|
7,280
-20.6%
0.57
USD 4,120
|
7,280
-20.6%
|
0.57
|
USD 4,120
|
|
|
2023-09-08 |
2023-09-06 |
PS
Planned sale
|
Seymour Albert
See Remarks
Executive Director
|
1,448
-1.0%
1.15
USD 1,665
|
1,448
-1.0%
|
1.15
|
USD 1,665
|
|
|
2023-08-07 |
2023-08-03 |
S
Sale
|
Jordan Julie
Chief Medical Officer
Officer
|
1,308
-14.9%
1.39
USD 1,818
|
1,308
-14.9%
|
1.39
|
USD 1,818
|
|
|
2023-08-07 |
2023-08-03 |
PS
Planned sale
|
Jordan Julie
Chief Medical Officer
Officer
|
109
-2.6%
1.39
USD 152
|
109
-2.6%
|
1.39
|
USD 152
|
|
|
2023-08-07 |
2023-08-03 |
PS
Planned sale
|
Jordan Julie
Chief Medical Officer
Officer
|
436
-10.1%
1.39
USD 606
|
436
-10.1%
|
1.39
|
USD 606
|
|
|
2023-08-04 |
2023-08-02 |
PS
Planned sale
|
Jordan Julie
Chief Medical Officer
Officer
|
99
-3.5%
1.31
USD 130
|
99
-3.5%
|
1.31
|
USD 130
|
|
|
2023-03-06 |
2023-03-02 |
PS
Planned sale
|
Alloway Paul
See Remarks
Officer
|
10,965
-39.6%
1.45
USD 15,863
|
10,965
-39.6%
|
1.45
|
USD 15,863
|
|
|
2023-01-11 |
2023-01-09 |
PS
Planned sale
|
TZIANABOS ARTHUR
Non-Executive Director
|
10,616
-8.9%
1.39
USD 14,762
|
10,616
-8.9%
|
1.39
|
USD 14,762
|
|
|
2023-01-11 |
2023-01-09 |
PS
Planned sale
|
Alloway Paul
See Remarks
Officer
|
3,090
-13.3%
1.39
USD 4,296
|
3,090
-13.3%
|
1.39
|
USD 4,296
|
|
|
2023-01-11 |
2023-01-09 |
PS
Planned sale
|
Blum Michael Lee
Chief Commercial Officer
Officer
|
2,454
-15.3%
1.39
USD 3,412
|
2,454
-15.3%
|
1.39
|
USD 3,412
|
|
|
2023-01-11 |
2023-01-09 |
PS
Planned sale
|
Smith W Bradford
See Remarks
Officer
|
3,729
-20.8%
1.39
USD 5,188
|
3,729
-20.8%
|
1.39
|
USD 5,188
|
|
|
2023-01-11 |
2023-01-09 |
PS
Planned sale
|
Seymour Albert
See Remarks
Executive Director
|
3,620
-2.5%
1.39
USD 5,033
|
3,620
-2.5%
|
1.39
|
USD 5,033
|
|
|
2022-01-12 |
2022-01-05 |
PS
Planned sale
|
Cohn Gabriel
Chief Medical Officer
Officer
|
1,661
-38.7%
3.78
USD 6,279
|
1,661
-38.7%
|
3.78
|
USD 6,279
|
|
|
2022-01-12 |
2022-01-05 |
PS
Planned sale
|
Smith W Bradford
CFO & Treasurer
Officer
|
2,182
-33.1%
3.78
USD 8,248
|
2,182
-33.1%
|
3.78
|
USD 8,248
|
|
|
2022-01-12 |
2022-01-05 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
Officer
|
1,661
-1.2%
3.78
USD 6,279
|
1,661
-1.2%
|
3.78
|
USD 6,279
|
|
|
2022-01-12 |
2022-01-05 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
5,354
-5.9%
3.78
USD 20,239
|
5,354
-5.9%
|
3.78
|
USD 20,239
|
|
|
2022-01-12 |
2022-01-05 |
PS
Planned sale
|
Kelly Timothy P
Chief Operating Officer
Officer
|
1,406
-38.7%
3.78
USD 5,315
|
1,406
-38.7%
|
3.78
|
USD 5,315
|
|
|
2021-02-09 |
2021-02-08 |
PS
Planned sale
|
Smith W Bradford
CFO & Treasurer
Officer
|
13,500
-100.0%
14.25
USD 192,425
|
13,500
-100.0%
|
14.25
|
USD 192,425
|
|
|
2021-02-05 |
2021-02-02 |
PS
Planned sale
|
Kelly Timothy P
See Remarks
Officer
|
500
-100.0%
13.00
USD 6,500
|
500
-100.0%
|
13.00
|
USD 6,500
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Kelly Timothy P
See Remarks
Officer
|
4,000
-100.0%
12.37
USD 49,460
|
4,000
-100.0%
|
12.37
|
USD 49,460
|
|
|
2021-01-14 |
2021-01-12 |
PS
Planned sale
|
Kelly Timothy P
See Remarks
Officer
|
500
-100.0%
13.00
USD 6,500
|
500
-100.0%
|
13.00
|
USD 6,500
|
|
|
2021-01-08 |
2021-01-07 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
Officer
|
5,103
-3.8%
12.05
USD 61,469
|
5,103
-3.8%
|
12.05
|
USD 61,469
|
|
|
2021-01-08 |
2021-01-06 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
Officer
|
9,897
-6.9%
12.06
USD 119,395
|
9,897
-6.9%
|
12.06
|
USD 119,395
|
|
|
2021-01-07 |
2021-01-05 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
Officer
|
10,000
-6.5%
11.44
USD 114,422
|
10,000
-6.5%
|
11.44
|
USD 114,422
|
|
|
2021-01-06 |
2021-01-04 |
PS
Planned sale
|
Kelly Timothy P
See Remarks
Officer
|
4,000
-100.0%
11.50
USD 45,983
|
4,000
-100.0%
|
11.50
|
USD 45,983
|
|
|
2020-12-28 |
2020-12-22 |
S
Sale
|
PARMAR KUSH
Non-Executive Director
|
20,000
-9.9%
12.82
USD 256,400
|
20,000
-9.9%
|
12.82
|
USD 256,400
|
|
|
2020-12-28 |
2020-12-22 |
S
Sale
|
5AM Ventures IV, L.P.
Large shareholder
|
20,000
-9.9%
12.82
USD 256,400
|
20,000
-9.9%
|
12.82
|
USD 256,400
|
|
|
2020-12-28 |
2020-12-22 |
S
Sale
|
PARMAR KUSH
Non-Executive Director
|
480,000
-9.9%
12.82
USD 6,153,600
|
480,000
-9.9%
|
12.82
|
USD 6,153,600
|
|
|
2020-12-28 |
2020-12-22 |
S
Sale
|
5AM Ventures IV, L.P.
Large shareholder
|
480,000
-9.9%
12.82
USD 6,153,600
|
480,000
-9.9%
|
12.82
|
USD 6,153,600
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
5AM Ventures IV, L.P.
Large shareholder
|
13,703
-6.4%
11.88
USD 162,792
|
13,703
-6.4%
|
11.88
|
USD 162,792
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
5AM Ventures IV, L.P.
Large shareholder
|
6,297
-2.8%
13.06
USD 82,244
|
6,297
-2.8%
|
13.06
|
USD 82,244
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
5AM Ventures IV, L.P.
Large shareholder
|
328,862
-6.4%
11.88
USD 3,906,881
|
328,862
-6.4%
|
11.88
|
USD 3,906,881
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
PARMAR KUSH
Non-Executive Director
|
13,703
-6.4%
11.88
USD 162,792
|
13,703
-6.4%
|
11.88
|
USD 162,792
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
PARMAR KUSH
Non-Executive Director
|
6,297
-2.8%
13.06
USD 82,244
|
6,297
-2.8%
|
13.06
|
USD 82,244
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
PARMAR KUSH
Non-Executive Director
|
328,862
-6.4%
11.88
USD 3,906,881
|
328,862
-6.4%
|
11.88
|
USD 3,906,881
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
5AM Ventures IV, L.P.
Large shareholder
|
151,138
-2.8%
13.06
USD 1,973,998
|
151,138
-2.8%
|
13.06
|
USD 1,973,998
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
PARMAR KUSH
Non-Executive Director
|
151,138
-2.8%
13.06
USD 1,973,998
|
151,138
-2.8%
|
13.06
|
USD 1,973,998
|
|
|
2020-03-18 |
2020-03-17 |
PS
Planned sale
|
Kelly Timothy P
See Remarks
Officer
|
1,315
-100.0%
13.01
USD 17,109
|
1,315
-100.0%
|
13.01
|
USD 17,109
|
|
|
2020-02-05 |
2020-02-03 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
12,500
-13.9%
16.16
USD 202,021
|
12,500
-13.9%
|
16.16
|
USD 202,021
|
|
|
2020-02-05 |
2020-02-03 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
|
12,000
-100.0%
16.16
USD 193,866
|
12,000
-100.0%
|
16.16
|
USD 193,866
|
|
|
2020-01-31 |
2020-01-30 |
S
Sale
|
Flynn James E
Large shareholder
|
509,970
-100.0%
15.45
USD 7,879,037
|
509,970
-100.0%
|
15.45
|
USD 7,879,037
|
|
|
2020-01-31 |
2020-01-29 |
S
Sale
|
Flynn James E
Large shareholder
|
8,857
-1.7%
15.45
USD 136,808
|
8,857
-1.7%
|
15.45
|
USD 136,808
|
|
|
2020-01-28 |
2020-01-28 |
S
Sale
|
Flynn James E
Large shareholder
|
65,891
-11.3%
15.51
USD 1,021,936
|
65,891
-11.3%
|
15.51
|
USD 1,021,936
|
|
|
2020-01-28 |
2020-01-27 |
S
Sale
|
Flynn James E
Large shareholder
|
193,359
-24.9%
15.77
USD 3,049,600
|
193,359
-24.9%
|
15.77
|
USD 3,049,600
|
|
|
2020-01-28 |
2020-01-24 |
S
Sale
|
Flynn James E
Large shareholder
|
380,256
-32.8%
15.69
USD 5,965,000
|
380,256
-32.8%
|
15.69
|
USD 5,965,000
|
|
|
2020-01-03 |
2020-01-02 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
|
6,000
-100.0%
20.50
USD 122,984
|
6,000
-100.0%
|
20.50
|
USD 122,984
|
|
|
2020-01-03 |
2020-01-02 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
|
9,133
-5.6%
20.50
USD 187,216
|
9,133
-5.6%
|
20.50
|
USD 187,216
|
|
|
2020-01-03 |
2020-01-02 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
12,500
-12.2%
20.50
USD 256,191
|
12,500
-12.2%
|
20.50
|
USD 256,191
|
|
|
2019-12-27 |
2019-12-24 |
S
Sale
|
Flynn James E
Large shareholder
|
151,233
-7.9%
21.95
USD 3,319,579
|
151,233
-7.9%
|
21.95
|
USD 3,319,579
|
|
|
2019-12-27 |
2019-12-24 |
S
Sale
|
Flynn James E
Large shareholder
|
198,767
-7.9%
21.95
USD 4,362,956
|
198,767
-7.9%
|
21.95
|
USD 4,362,956
|
|
|
2019-12-23 |
2019-12-23 |
S
Sale
|
Flynn James E
Large shareholder
|
56,595
-2.9%
21.83
USD 1,235,435
|
56,595
-2.9%
|
21.83
|
USD 1,235,435
|
|
|
2019-12-23 |
2019-12-23 |
S
Sale
|
Flynn James E
Large shareholder
|
74,384
-2.9%
21.83
USD 1,623,758
|
74,384
-2.9%
|
21.83
|
USD 1,623,758
|
|
|
2019-12-23 |
2019-12-20 |
S
Sale
|
Flynn James E
Large shareholder
|
9,130
-0.5%
21.50
USD 196,297
|
9,130
-0.5%
|
21.50
|
USD 196,297
|
|
|
2019-12-23 |
2019-12-20 |
S
Sale
|
Flynn James E
Large shareholder
|
11,999
-0.5%
21.50
USD 257,981
|
11,999
-0.5%
|
21.50
|
USD 257,981
|
|
|
2019-12-23 |
2019-12-19 |
S
Sale
|
Flynn James E
Large shareholder
|
5,454
-0.3%
21.68
USD 118,219
|
5,454
-0.3%
|
21.68
|
USD 118,219
|
|
|
2019-12-23 |
2019-12-19 |
S
Sale
|
Flynn James E
Large shareholder
|
7,168
-0.3%
21.68
USD 155,371
|
7,168
-0.3%
|
21.68
|
USD 155,371
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
Officer
|
9,300
-5.4%
16.23
USD 150,970
|
9,300
-5.4%
|
16.23
|
USD 150,970
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
Officer
|
6,000
-100.0%
16.21
USD 97,266
|
6,000
-100.0%
|
16.21
|
USD 97,266
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
12,500
-10.9%
16.25
USD 203,176
|
12,500
-10.9%
|
16.25
|
USD 203,176
|
|
|
2019-12-03 |
2019-11-29 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
Officer
|
9,300
-5.1%
16.06
USD 149,390
|
9,300
-5.1%
|
16.06
|
USD 149,390
|
|
|
2019-12-03 |
2019-11-29 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
Officer
|
6,000
-100.0%
16.00
USD 96,000
|
6,000
-100.0%
|
16.00
|
USD 96,000
|
|
|
2019-12-03 |
2019-11-29 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
12,500
-9.8%
16.04
USD 200,559
|
12,500
-9.8%
|
16.04
|
USD 200,559
|
|
|
2019-10-02 |
2019-10-01 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
100
-0.1%
18.23
USD 1,823
|
100
-0.1%
|
18.23
|
USD 1,823
|
|
|
2019-10-02 |
2019-10-01 |
PS
Planned sale
|
TZIANABOS ARTHUR
President & CEO
Executive Director
|
12,400
-8.9%
17.39
USD 215,645
|
12,400
-8.9%
|
17.39
|
USD 215,645
|
|
|
2019-10-02 |
2019-10-01 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
|
100
-100.0%
18.23
USD 1,823
|
100
-100.0%
|
18.23
|
USD 1,823
|
|
|
2019-10-02 |
2019-10-01 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
|
5,900
-98.3%
17.38
USD 102,544
|
5,900
-98.3%
|
17.38
|
USD 102,544
|
|
|
2019-10-02 |
2019-10-01 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
|
100
-0.1%
18.23
USD 1,823
|
100
-0.1%
|
18.23
|
USD 1,823
|
|
|
2019-10-02 |
2019-10-01 |
PS
Planned sale
|
Seymour Albert
Chief Scientific Officer
|
9,200
-4.8%
17.38
USD 159,936
|
9,200
-4.8%
|
17.38
|
USD 159,936
|
|
|
2019-09-09 |
2019-09-05 |
PS
Planned sale
|
Kelly Timothy P
See Remarks
|
1,166
-100.0%
19.94
USD 23,251
|
1,166
-100.0%
|
19.94
|
USD 23,251
|
|
|
2019-09-05 |
2019-09-03 |
PS
Planned sale
|
Smith W Bradford
CFO, Treasurer & Secretary
|
6,000
-100.0%
18.74
USD 112,419
|
6,000
-100.0%
|
18.74
|
USD 112,419
|
|
